Osthole suppresses fatty acid synthase expression in HER2-overexpressing breast cancer cells through modulating Akt/mTOR pathway

Journal of Agricultural and Food Chemistry

Volumn 58, Issue 8, 2010, Pages 4786-4793

  Lin, Victor Chia Hsiang ^a   Chou, Chun Hung ^b   Lin, Ying Chao ^c,d   Lin, Jia Ni ^b   Yu, Chien Chih ^b   Tang, Chih Hsin ^e   Lin, Hui Yi ^b   Way, Tzong Der ^b  

^a I SHOU UNIVERSITY   (Taiwan)

^b CHINA MEDICAL UNIVERSITY   (Taiwan)

^c NATIONAL CHUNG HSING UNIVERSITY   (Taiwan)

^d BUDDHIST TZU CHI GENERAL HOSPITAL   (Taiwan)

^e CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Apoptosis; Cytotoxicity; Fatty acid synthase; Osthole

Indexed keywords

COUMARIN DERIVATIVE; FATTY ACID SYNTHASE; MAMMALIAN TARGET OF RAPAMYCIN; OSTHOLE; PROTEIN KINASE B; PROTEIN SERINE THREONINE KINASE; SIGNAL PEPTIDE;

ARTICLE; BREAST TUMOR; DRUG ANTAGONISM; ENZYMOLOGY; HUMAN; METABOLISM; PATHOLOGY; PROTO ONCOGENE; TUMOR CELL LINE;

BREAST NEOPLASMS; CELL LINE, TUMOR; COUMARINS; FATTY ACID SYNTHETASE COMPLEX; GENES, ERBB-2; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS C-AKT;

CNIDIUM; CNIDIUM MONNIERI;

EID: 77951279924     PISSN: 00218561     EISSN: 15205118     Source Type: Journal    
DOI: 10.1021/jf100352c     Document Type: Article

References (30)

1. Kuhajda, F. P. Fatty-acid synthase and human cancer: new perspectives on its role in tumor biology Nutrition 2000, 16, 202-208
2. Wakil, S. J. Fatty acid synthase, a proficient multifunctional enzyme Biochemistry 1989, 28, 4523-4530
3. Kuhajda, F. P. Fatty acid synthase and cancer: new application of an old pathway Cancer Res. 2006, 66, 5977-5980
4. Huang, C. H.; Tsai, S. J.; Wang, Y. J.; Pan, M. H.; Kao, J. Y.; Way, T. D. EGCG inhibits protein synthesis, lipogenesis, and cell cycle progression through activation of AMPK in p53 positive and negative human hepatoma cells Mol. Nutr. Food Res. 2009, 53, 1156-1165
5. Stearns, V.; Schneider, B.; Henry, N. L.; Hayes, D. F.; Flockhart, D. A. Breast cancer treatment and ovarian failure: risk factors and emerging genetic determinants Nat. Rev. Cancer 2006, 6, 886-893
6. Gullo, G.; Bettio, D.; Torri, V.; Masci, G.; Salvini, P.; Santoro, A. Level of HER2/neu gene amplification as a predictive factor of response to trastuzumab-based therapy in patients with HER2-positive metastatic breast cancer Invest. New Drugs 2009, 27, 179-183
7. Yu, D.; Hung, M. C. Overexpression of ErbB2 in cancer and ErbB2-targeting strategies Oncogene 2000, 19, 6115-6121
8. Kumar-Sinha, C.; Ignatoski, K. W.; Lippman, M. E.; Ethier, S. P.; Chinnaiyan, A. M. Transcriptome analysis of HER2 reveals a molecular connection to fatty acid synthesis Cancer Res. 2003, 63, 132-139
9. Menendez, J. A.; Mehmi, I.; Verma, V. A.; Teng, P. K.; Lupu, R. Pharmacological inhibition of fatty acid synthase (FAS): A novel therapeutic approach for breast cancer chemoprevention through its ability to suppress Her-2/neu (erbB-2) oncogene-induced malignant transformation Mol. Carcinog. 2004, 41, 164-178
10. Alli, P. M.; Pinn, M. L.; Jaffee, E. M.; McFadden, J. M.; Kuhajda, F. P. Fatty acid synthase inhibitors are chemopreventive for mammary cancer in neu-N transgenic mice Oncogene 2005, 24, 39-46
11. Pan, M. H.; Lai, C. S.; Dushenkov, S.; Ho, C. T. Modulation of inflammatory genes by natural dietary bioactive compounds J. Agric. Food Chem. 2009, 57, 4467-4477
12. Zhang, Q.; Qin, L.; He, W.; Van Puyvelde, L.; Maes, D.; Adams, A.; Zheng, H.; De Kimpe, N. Coumarins from Cnidium monnieri and their antiosteoporotic activity Planta Med. 2007, 73, 13-19
13. Okamoto, T.; Kawasaki, T.; Hino, O. Osthole prevents anti-Fas antibody-induced hepatitis in mice by affecting the caspase-3-mediated apoptotic pathway Biochem. Pharmacol. 2003, 65, 677-681
14. Matsuda, H.; Tomohiro, N.; Ido, Y.; Kubo, M. Anti-allergic effects of cnidii monnieri fructus (dried fruits of Cnidium monnieri) and its major component, osthol Biol. Pharm. Bull. 2002, 25, 809-812
15. Luszczki, J. J.; Andres-Mach, M.; Cisowski, W.; Mazol, I.; Glowniak, K.; Czuczwar, S. J. Osthole suppresses seizures in the mouse maximal electroshock seizure model Eur. J. Pharmacol. 2009, 607, 107-109
16. Chou, S. Y.; Hsu, C. S.; Wang, K. T.; Wang, M. C.; Wang, C. C. Antitumor effects of Osthol from Cnidium monnieri: an in vitro and in vivo study Phytother. Res. 2007, 21, 226-230
17. Sun, F.; Xie, M. L.; Zhu, L. J.; Xue, J.; Gu, Z. L. Inhibitory effect of osthole on alcohol induced fatty liver in mice Dig. Liver Dis. 2009, 41, 127-133
18. Yu, D.; Jing, T.; Liu, B.; Yao, J.; Tan, M.; McDonnell, T. J.; Hung, M. C. Overexpression of ErbB2 blocks Taxol-induced apoptosis by upregulation of p21Cip1, which inhibits p34Cdc2 kinase Mol. Cell 1998, 2, 581-591
19. Way, T. D.; Lin, H. Y.; Kuo, D. H.; Tsai, S. J.; Shieh, J. C.; Wu, J. C.; Lee, M. R.; Lin, J. K. Pu-erh tea attenuates hyperlipogenesis and induces hepatoma cells growth arrest through activating AMP-activated protein kinase (AMPK) in human HepG2 cells J. Agric. Food Chem. 2009, 57, 5257-5264
20. Kuo, P. T.; Lin, T. P.; Liu, L. C.; Huang, C. H.; Lin, J. K.; Kao, J. Y.; Way, T. D. Penta-O-galloyl-beta-D-glucose suppresses prostate cancer bone metastasis by transcriptionally repressing EGF-induced MMP-9 expression J. Agric. Food Chem. 2009, 57, 3331-3339
21. Yang, Y. A.; Han, W. F.; Morin, P. J.; Chrest, F. J.; Pizer, E. S. Activation of fatty acid synthesis during neoplastic transformation: role of mitogen-activated protein kinase and phosphatidylinositol 3-kinase Exp. Cell Res. 2002, 279, 80-90
22. Yu, D.; Liu, B.; Tan, M.; Li, J.; Wang, S. S.; Hung, M. C. Overexpression of c-erbB-2/neu in breast cancer cells confers increased resistance to Taxol via mdr-1-independent mechanisms Oncogene 1996, 13, 1359-1365
23. Menendez, J. A.; Vellon, L.; Colomer, R.; Lupu, R. Pharmacological and small interference RNA-mediated inhibition of breast cancer-associated fatty acid synthase (oncogenic antigen-519) synergistically enhances Taxol (paclitaxel)-induced cytotoxicity Int. J. Cancer 2005, 115, 19-35
24. Menendez, J. A.; Vellon, L.; Mehmi, I.; Oza, B. P.; Ropero, S.; Colomer, R.; Lupu, R. Inhibition of fatty acid synthase (FAS) suppresses HER2/neu (erbB-2) oncogene overexpression in cancer cells Proc. Natl. Acad. Sci. U.S.A. 2004, 101, 10715-10720
25. Weinstein, I. B. Cancer. Addiction to oncogenes - the Achilles heal of cancer Science 2002, 297, 63-64
26. Wang, H. Q.; Altomare, D. A.; Skele, K. L.; Poulikakos, P. I.; Kuhajda, F. P.; Di, C. A.; Testa, J. R. Positive feedback regulation between AKT activation and fatty acid synthase expression in ovarian carcinoma cells Oncogene 2005, 24, 3574-3582
27. Yoon, S.; Lee, M. Y.; Park, S. W.; Moon, J. S.; Koh, Y. K.; Ahn, Y. H.; Park, B. W.; Kim, K. S. Up-regulation of Acetyl-CoA Carboxylase {alpha} and Fatty Acid Synthase by Human Epidermal Growth Factor Receptor 2 at the Translational Level in Breast Cancer Cells J. Biol. Chem. 2007, 282, 26122-26131
28. Zhou, X.; Tan, M.; Stone Hawthorne, V.; Klos, K. S.; Lan, K. H.; Yang, Y.; Yang, W.; Smith, T. L.; Shi, D.; Yu, D. Activation of the Akt/mammalian target of rapamycin/4E-BP1 pathway by ErbB2 overexpression predicts tumor progression in breast cancers Clin. Cancer Res. 2004, 10, 6779-6788
29. Mondesire, W. H.; Jian, W.; Zhang, H.; Ensor, J.; Hung, M. C.; Mills, G. B.; Meric-Bernstam, F. Targeting mammalian target of rapamycin synergistically enhances chemotherapy-induced cytotoxicity in breast cancer cells Clin. Cancer Res. 2004, 10, 7031-7042
30. Davoli, A.; Hocevar, B. A.; Brown, T. L. Progression and treatment of HER2-positive breast cancer Cancer Chemother. Pharmacol. 2010, 65, 611-623